Dysfunctional adipose tissue represents a hallmark of type 2 diabetes and systemic insulin resistance, characterized by fibrotic deposition of collagens and increased immune cell infiltration within the depots. Here we generate an inducible model of loss of function of the protein phosphatase and tensin homolog (PTEN), a phosphatase critically involved in turning off the insulin signal transduction cascade, to assess the role of enhanced insulin signaling specifically in mature adipocytes. These mice gain more weight on chow diet and short-term as well as long-term high-fat diet exposure. Despite the increase in weight, they retain enhanced insulin sensitivity, show improvements in oral glucose tolerance tests, display reduced adipose tissue inflammation and maintain elevated adiponectin levels. These improvements also lead to reduced hepatic steatosis and enhanced hepatic insulin sensitivity. Prolonging insulin action selectively in the mature adipocyte is therefore sufficient to maintain normal systemic metabolic homeostasis.
Introduction
Adipose tissue is an advanced endocrine organ used for the long-term storage of energy dense lipids (1) . Insulin is primarily responsible for the enhanced uptake of glucose into tissues such as muscle and adipose tissue, suppressing glucagon release from the pancreatic α cells and concurrently suppressing glucose production and release from hepatocytes.
Failure to properly respond to insulin in these respective tissues as a result of insulin resistance triggers elevated glucagon levels and elevated blood glucose levels in peripheral tissues. In the long term, this leads to glucose intolerance and ultimately, type 2 diabetes.
Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms While we appreciate the essential nature of the adipocyte as an effective storage cell for excess triglycerides with potent protective action against lipotoxic effects associated with high fat diet (HFD) exposure, the systemic consequences of prolonged insulin signaling in the mature adipocyte are not well understood. A loss of function of the insulin receptor in adipocytes, the "FIRKO" mouse, displays a lean phenotype and protection against HFDinduced glucose intolerance and lowered fasting triglycerides (2) . A number of additional components of the different branches of the insulin receptor signal transduction cascade have been eliminated from the adipocyte. Adipocyte-specific deletion of Grb10, for instance, leads to inhibition of lipolysis and reduced thermogenesis (3) . Adipocyte-specific loss of Glut4, the insulin-responsive glucose transporter, showed a markedly different phenotype (4) . Using the ap2-CRE mouse to target the Glut4 gene in adipocytes, Able and colleagues demonstrated significant glucose intolerance and insulin resistance, while adipose mass was preserved. Furthermore, insulin resistance developed in the liver and muscle, secondary to adipose dysfunction. These two observations reflect a dichotomous response to "insulin resistance" in adipose tissue. With the loss of the receptor, we see improvements in systemic glucose tolerance, whereas the loss of a key effector of insulin action, Glut4, results in marked glucose intolerance.
Of interest in this context is the specific role of insulin sensitivity of adipose tissue in orchestrating the synthesis and release of adiponectin. Adiponectin, first identified in 1995, has potent insulin sensitizing properties (5) . Indeed, in both humans and mice, adiponectin levels strongly correlate with insulin sensitivity and are generally inversely correlated with BMI (6) . Although these associations are strong, some of the most insulin resistant adipose tissues paradoxically produces extremely high levels of adiponectin. In a clinical study, Semple and colleagues identified a cohort of patients with anti-insulin receptor antibodies that render them extremely insulin resistant; surprisingly, these individuals had dramatically increased adiponectin levels in circulation (7) . Furthermore, mice harboring a knockout of the insulin receptor in adipocytes had elevated intra-adipose tissue levels of adiponectin (2) . In contrast, the vast majority of other models intervening with the canonical insulin signal transduction cascade display lower adiponectin levels. Therefore, with respect to the impact of insulin signaling on adiponectin production, we observe dichotomous consequences, depending on where within the insulin signal transduction cascade the system is tampered with.
In an effort to mechanistically better understand the impact of insulin signaling on adiponectin secretion, we have generated mice that allow us to manipulate insulin sensitivity in adipocytes at the post-receptor level. The phosphatase PTEN (phosphatase and tensin homolog) is a known negative regulator of insulin signaling (8) . We have generated a model which allows us to inducibly delete the PTEN gene specifically in mature adipocytes, thereby greatly prolonging insulin action and enhancing the insulin sensitivity, while avoiding any developmental issues associated with the loss of function of this important phosphatase. Using an adiponectin promoter-driven rtTA transgenic mouse, crossed with the tetracycline response element driven cre-recombinase transgenic mouse (TRE-CRE) in the background of mice carrying a PTEN locus flanked by loxP sites, we can inducibly eliminate PTEN from mature adipocytes upon administration of doxycycline in the feed. This transgenic system has previously been used to track mature adipocytes during embryonic and adult life, and demonstrated to be highly specific and sensitive (9) . Using this model, we can determine the effects of enhanced insulin signaling on adipocytes in adult mice, and can further delineate the impact of prolonged high-level insulin signaling on modulating adiponectin levels in serum and the subsequent impact on whole body metabolism.
Results

Inducible and adipocyte-specific elimination of PTEN
To determine whether the adipocyte-specific inducible PTEN knockout (referred to as AiPKO) mouse is effectively eliminating PTEN expression, AiPKO and control mice were placed on doxycycline diet (600mg kg −1 ) for a period of 4 or 30 days. Subcutaneous and gonadal adipose depots were isolated from these mice, fat pads were digested with collagenase and adipocytes were separated from the stromal vascular contents by floatation. Isolated adipocytes were subjected to RNA extraction, and cDNA synthesis. RT-qPCR analysis on this cDNA confirmed that after 30 days of exposure to doxycycline, PTEN mRNA expression in adipocytes from both subcutaneous and gonadal depots is decreased by over 98% (Fig. 1A) . To further confirm these results, adipose tissue was extracted from mice fed doxycycline diet for 8 weeks. Analysis of gonadal adipose tissue by immunofluorescence microscopy confirms widespread loss of PTEN protein from AiPKO adipocytes, while the PTEN signal clearly remained stable in the control adipocytes (Fig.  1B) .
As PTEN is a known phosphatase of PiP 3 , a key second messenger in the insulin signaling transduction cascade and an activator of AKT, we wished to determine if the loss of PTEN had functional consequences in a cell autonomous manner. Adipocytes were isolated from the subcutaneous adipose depot via collagenase digestion and floatation from AiPKO or control mice after 6 weeks of doxycycline chow diet (600mg kg −1 ) following a 5 hour fast. These adipocytes were stimulated with 1nM insulin for 10 minutes, at which time the cells were lysed and proteins extracted for Western blot analysis. The AiPKO adipocytes demonstrated enhanced activation of the insulin signaling pathway as judged by increased phosphorylation of AKT (Fig. 1C) . To confirm this result in-vivo, both control and AiPKO mice were placed on a doxycycline diet (600mg kg −1 ). After 4 weeks, mice were fasted for 4 hours then I.P. injected with insulin (0.5 IU kg −1 ) and sacrificed at 0, 5, 10 or 15 minutes. The adipose tissue from these mice was harvested; proteins extracted in TNET buffer containing protease and phosphatase inhibitors, and then subjected to western blot analysis. This analysis demonstrated enhanced AKT phosphorylation at all time points, as well as enhanced P-42/P-44 activation indicating enhanced insulin signaling through both pathways of the insulin receptor (Fig. 1D ).
To determine whether the observed enhanced insulin signaling in adipose tissue had functional implications for adiponectin secretion, tail vein blood was drawn and Western blotting was performed on serum of mice that had been fed doxycycline containing chow diet for 4 weeks. Despite loss of PTEN from the adipocytes, the blot revealed no significant changes in circulating adiponectin levels in the AiPKO mice compared to controls (Fig. 1E) . At the time of blood collection, we noted that the AiPKO mice had gained more weight than the control mice over the course of the 4 weeks of doxycycline administration, though these differences were statistically not significant (Weight Change-Control 13.1%, AiPKO 21.0%, P=0.082). Furthermore, during blood collection, serum glucose was measured. AiPKO mice showed dramatically lower circulating glucose levels to a degree that these mice suffer from hypoglycemia (Fig. 1F) . To determine if this lower glucose was pertinent to overall glucose homeostasis, an OGTT was performed on the mice. The AiPKO mice demonstrated significantly better glucose handling compared to the control mice during this challenge (Fig. 1G) . These phenotypic changes demonstrating increased weight gain with concomitant lowering of fasted blood glucose and improved glucose tolerance upon a challenge, observed on a standard chow diet, prompted us to test the impact of enhanced metabolic stress on this model.
AiPKO mice are resistant to high fat diet insulin resistance
AiPKO mice, starting around 6-7 weeks of age, were switched to a high fat diet (HFD) containing 600 mg kg −1 doxycycline. After 6 weeks of the HFD challenge, AiPKO mice had gained significantly more weight compared to controls ( Fig. 2A) . At that time, we subjected the mice to an oral glucose tolerance test. Mice were fasted for 4 hours and then gavaged with 2.5g kg −1 glucose (Fig. 2B) . The AiPKO mice demonstrated significantly improved glucose tolerance compared to controls despite the overall weight increase. We also assessed insulin levels over the course of the glucose challenge. AiPKO mice displayed much lower insulin levels compared to their wildtype littermates (Fig. 2C) , consistent with an overall improvement in systemic insulin sensitivity.
As the AiPKO mice displayed much lower insulin levels during the glucose challenge, we wished to determine whether this decreased insulin secretion was also observed in the setting of a pharmacologic challenge. Mice were subjected to a β3-adrenergic receptor agonist stimulation (with compound CL316,243 at 0.5 mg kg −1 body weight), injected intraperitoneally following a 4 hour fast. This β3 adrenergic receptor stimulation leads to enhanced lipolysis, as well as a rapid and massive release of insulin (10) . Over the course of the experiment, the AiPKO mice displayed reduced glucose levels, resulting in significant hypoglycemia over the entire course of the experiment (Fig. 2D) . In contrast, the wildtype mice displayed hyperglycemia at all times. At every time point, except for the 5 minute mark, both wildtype and AiPKO mice overlapped with respect to the increase in lipolysis as judged by significantly increased non-esterified fatty acids (NEFAs) in circulation; in contrast however, the AipKO mice demonstrated a disproportionately higher level of glycerol release (Figs. 2E and 2F) . Interestingly, the NEFA levels in both genotypes were overlapping, even though the insulin levels in the AIPKO mice were dramatically lower compared to wildtype controls (Fig. 2G ). In light of the fact that there are no β3 adrenergic receptors present on rodent β cells that could mediate the insulin release, these results further underscore our previous suggestion that insulin release from the β cell under these conditions is independent of NEFAs derived from adipocytes, consistent with the release of another secreted factor from adipocytes or a neuronally-mediated pathway mediating β3 adrenergic receptor stimulation in adipocytes to prompt insulin release from β-cells.
As these mice demonstrated dramatically lower insulin levels during both the OGTT as well as the β3-adrenergic stimulation, we wished to assess whole body insulin sensitivity after 6 weeks of HFD feeding. Mice were fasted for 4 hours and then injected with a submaximal dose of insulin (0.5 IU kg −1 ). Blood glucose was monitored at 15, 30, 60, 90 and 120 minutes. The AiPKO mice demonstrated a much greater reduction in blood glucose compared to their wildtype littermates (Fig. 2H ). This data suggests that these mice are significantly more insulin sensitive and that alterations of adipose tissue insulin sensitivity is sufficient to completely ameliorate the insulin resistance brought on by high fat diet feeding.
To determine any changes with respect to adipose tissue homeostasis at the cellular level, gonadal and subcutaneous adipose depots were isolated. qPCR analysis was performed on cDNA samples obtained from these fat pads in an effort to gauge alterations in the inflammatory tone, commonly elevated following HFD exposure. Among the genes tested, TNFα was significantly reduced in the subcutaneous adipose tissue of the AiPKO mice compared to wildtype mice, and measurements in gonadal tissue showed similar trends (Fig.  2I ). This is a reflection of the overall improved health status of the fat pads in the AipKO mice.
Since the AiPKO mice demonstrated increased weight gain with improved glucose tolerance following the HFD challenge, we assessed whether this leads to any alterations in circulating adiponectin. Despite the widely-established inverse relationship of fat mass with adiponectin levels in circulation, and the generalized increased overall adiposity prompted by the lack of PTEN in the adipocyte, AiPKO mice placed on HFD containing doxycycline for 6 weeks demonstrated significantly higher serum adiponectin compared to controls as judged by western blot analysis of serum (Fig. 3A) . NMR analysis of these mice revealed an increase in total body adiposity with a concomitant relative decrease in lean body mass (Fig. 3B ).
Metabolic Expenditure Analysis
In an effort to identify the reasons responsible for the increased fat mass in the AiPKO mice, we subjected a separate cohort to analysis of metabolic chambers. 6 week-old AiPKO mice and their wildtype littermates were placed on HFD-doxycycline containing food. 16 days later, mice were placed into metabolic chambers for acclimatization and on day 20 following the initiation of HFD, data collection was initiated. AiPKO mice ate significantly more during the middle of the daytime sleep cycle (from 9am-3pm on a standard 6am-6pm light cycle) (Fig. 3C ). However, of note is that the overall food intake integrated over the course of the entire 24 hour period was not changed (Fig. 3D ). As the central hypothalamic axis is responsible for food intake, we sought to determine whether the AiPKO mice had alterations in the anorectic hormone leptin. Serum was collected from mice which had been fed HFD containing doxycycline (600mg kg −1 ) for 8 weeks. This serum was analyzed by ELISA for leptin and demonstrated that the AiPKO mice had elevated leptin levels compared to the control mice when controlling for body weight (Fig 3E) . This data suggests that although enhanced insulin signaling in adipose tissue may increase leptin secretion, these mice still exhibit leptin resistance.
In an effort to identify other mechanisms of increased weight gain in the AiPKO mice, we looked at other metabolically active tissues. A primary mediator of energy expenditure is the activity of brown adipose tissue (BAT). This thermogenic adipose depot is capable of dissipating a great deal of energy and we determined whether our mice had any alterations in BAT as previous reports using the adiponectin-rtTA mouse demonstrated some activity in at least a subset of brown adipocytes (9) . AiPKO and control mice were placed on a HFD containing doxycycline (600mg kg −1 ) for 8 weeks. At this time, the mice were sacrificed and RNA was extracted and cDNA synthesized from the brown adipose tissue. RT-qPCR analysis of the brown adipose tissue revealed a significant down regulation of brown adipose associated genes including UCP-1, PGC1-α and PRDM16 in the AiPKO mice compared to controls (Fig. 3F) . This data indicates a potential decrease in overall energy expenditure potentially explaining the increased weight gain observed. However, the AiPKO mice did not display any significant alterations in VO 2 , VCO 2 , RER and overall food consumption during the metabolic cage analysis (Fig. G-I) . Despite the lack of significant alterations in these metabolic parameters, the AiPKO mice moved significantly less than the wildtype littermates in the y-axis, and showed a trend toward reduced movement in the x-axis (Fig.  3J ). This data suggest that decreased movement and increased food consumption during resting hours are likely to account for the increased overall weight gain seen in AiPKO mice.
PTEN loss restores insulin sensitivity after HFD exposure
To determine if loss of PTEN from adipocytes could rescue a pre-existing diabetic phenotype induced by high fat diet feeding, AiPKO mice and their wildtype littermates were subjected to 8 weeks of HFD feeding starting at 6 weeks of age. At 8 weeks post initiation of HFD, an oral glucose tolerance test revealed no differences between the control mice and the AiPKOs (Fig. 3K ). Mice were then switched to a HFD doxycycline containing diet and were monitored longitudinally. While the weights always trended towards a slight increase in the AiPKO mice after initiation of dox exposure, these differences never reached statistical significance (Fig. 3L) . At 4 weeks following the switch to doxycycline containing chow, mice were again subjected to an oral glucose tolerance test. The AiPKO mice demonstrated significant improvements compared to their control littermates (Fig. 3M) . As before, insulin levels in these AiPKO mice were significantly lower than the controls (Fig. 3N ). These observations indicate that the loss of PTEN in the adipocyte, i.e. a selective and inducible improvement in adipocytes post exposure to HFD, prompts a reversal of a pre-existing, established diabetic phenotype.
AiPKO mice after a long-term HFD insult
To determine whether the metabolic advantages conferred upon the AiPKO mice due to the absence of PTEN were long-lasting or whether some resistance to high PTEN starts to appear over time, mice were subjected to prolonged HFD feeding. Body weights of AiPKO mice were significantly elevated after 4 weeks and displayed a trend towards an increase in body weights compared to their control littermates over 24 weeks, though never reaching statistical significance thereafter (Fig. 4A) . After 5 months of HFD feeding, AiPKO mice were subject to an oral glucose tolerance test (OGTT) (Fig. 4B) . Even after this prolonged metabolic insult, the AiPKO mice handled a glucose bolus much more effectively. It is also apparent that the baseline fasting glucose levels (at the beginning of the OGTT) were much lower than in the control group. Furthermore, insulin levels during the OGTT were a fraction of the levels in the control mice, further illustrating a highly stable phenotype that maintains dramatic improvements in metabolism even after a prolonged metabolic insult (Fig. 4C) . Insulin was injected into these mice after a 4 hour fast. Fat pads were then harvested, and their weights assessed. AiPKO mice had considerably larger subcutaneous fat depots, while the gonadal tissue was unaffected (Fig. 4D) . As adipose tissue can expand via hypertrophy or hyperplasia, we analyzed sections of both gonadal and subcutaneous adipose sections for cell number (Fig. 4E+F) . This analysis revealed similar numbers of cells per field in the sections, regardless of genotype. We conclude therefore that the significant expansion of the subcutaneous adipose depot in the AiPKO mice was due predominantly to an increase in cell number in the tissue, i.e. hyperplasia, a distinctive feature of healthy adipose expansion.
In parallel to the experiments above, we determined whether the loss of PTEN in adipose tissue was protective for the development of fatty liver after 5 months of HFD feeding. Histological examination of the liver demonstrated significant fat accumulation in the control mice. This stood in stark contrast to the situation in the AiPKO mice, which lacked fat accumulation in their livers after 5 months of high fat diet feeding (Fig. 4G) . To determine whether this lack of lipid accumulation had functional implications, the livers from the insulin-stimulated mice were also analyzed for phospho-AKT levels. AiPKO mice showed significantly greater AKT phosphorylation compared to their wildtype littermate controls (Fig. 4H) . Of note is the fact that total AKT levels also increase quite substantially in the AiPKO mice. This demonstrates the significant protective effects on hepatic insulin sensitivity upon selective improvements in insulin-sensitivity in adipocytes.
To determine whether the long-term high fat diet feeding had caused lasting alterations at the cellular level in the adipose tissue, gross structural examination under auto-fluorescent conditions revealed no change in adipocyte size or number (Fig. 4E) . To further confirm any alterations to the adipose tissue the fat pads of these mice were subjected to RT-qPCR and immunofluorescence analysis. RT-qPCR data shows decreased F4/80 expression and significantly less IL-6 production in the gonadal fat depots of AiPKO mice, without significant changes of these immune markers in the subcutaneous depot (Fig. 4I) . In contrast to the short-term HFD feeding, the long-term HFD feeding did not result in statistically significant changes in TNFα expression. To further confirm the increase in macrophage accumulation, immuno-fluorescent staining for Mac2 in the gonadal fat pad was performed. This analysis demonstrated highly elevated macrophage infiltration in the control mice versus the AiPKO, confirming at the protein level the RT-qPCR analysis (Fig. 4J) .
Discussion
Only one previous manipulation of the insulin receptor cascade leading to an increase in insulin signaling in the adipocyte has been described (11) , and none of the critical constituents have been inducibly eliminated selectively from the mature adipocyte only. In the report by Kurlawalla-Martinez and colleagues, the authors used a constitutive aP2-cre line to eliminate PTEN from adipocytes. Their results differed substantially from ours, and these differences likely stem from two major sources: aP2-driven Cre expression may extend to cell types in other tissues under some circumstances, though this can be controlled for (12) . More importantly, aP2-driven transgene expression can eliminate target genes in early pre-adipocyte progenitors, thereby leading to a developmental phenotype that masks the role of the target protein in the mature adipocyte. The latter of these effects presumably resulted in compensatory developmental adaptations. As a result, these authors failed to see changes in body weight or fasting blood glucose levels, both of which are highly apparent upon elimination of PTEN exclusively from the mature adipocyte, and lead to an underestimation of the relevance of PTEN action in the adipocyte.
To put our observations into additional context, another manuscript on the topic was previously published by Komazawa and colleagues (13). The phenotype described for their adipocyte-specific PTEN null model (employing a constitutive adiponectin promoter-driven Cre) was fundamentally different from what we describe here, and more importantly, these observation were not reproducible, and the paper was subsequently retracted (14) .
The use of inducible transgenic models therefore allows for the evaluation of gene function in the adult mouse and enables a more accurate depiction of the physiological impact of a given protein as compared to congenital loss-of-function approaches that affect the development of the tissue. To achieve this in the context of adipose tissue insulin signaling, we used an adiponectin promoter driven rtTA cassette coupled with a TRE-CRE transgenic mouse to inducibly eliminate a floxed PTEN locus from mature adipocytes. Upon confirming that our inducible model effectively and specifically leads to loss of function of PTEN in adipocytes, we assessed the impact of this alteration on mature adipocytes locally at the cell autonomous level as well as its impact on systemic metabolism. Overall, the loss of PTEN in the mature adipocyte leads to increased insulin sensitivity in multiple peripheral tissues, and a greatly improved metabolic phenotype upon acute and chronic exposure to high fat diets. This demonstrates that selective improvements in insulin sensitivity at the level of the adipocyte are sufficient to improve whole body glucose homeostasis.
In clinical studies as well as rodent and non-human primate studies, the levels of the circulating protein adiponectin have been tightly correlated with insulin sensitivity (6) . Here, we have the surprising finding that animals with highly insulin sensitive adipose tissue lack a corresponding increase in circulating adiponectin under basal conditions. As the adipose tissue in the AiPKO mice demonstrates increased insulin sensitivity in both arms of the insulin response pathway following HFD challenge, not only the PI3-AKT branch, we argue that insulin sensitivity in adipose tissue per se is not sufficient to mediate the regulation of circulating adiponectin (Fig 1D) . This data is supported by clinical studies demonstrating that subjects producing endogenous anti-insulin receptor antibodies display massively elevated circulating adiponectin despite a very high level of insulin resistance (7). Many questions remain as to how the release of adiponectin is regulated by local insulin sensitivity, but a number of studies hint at mitochondrial metabolism playing a major role in determining how much adiponectin is produced and released from the adipocyte (15) .
Upon challenging our mice with a HFD, a condition which caused the AiPKO mice to gain significantly more weight, we saw increased circulating adiponectin relative to the control mice. With their greater percent body fat and increased insulin sensitivity these mice do not display the drastic decrease in circulating adiponectin commonly seen in insulin resistant states. This observation is highly reminiscent of the clinical setting in which patients exposed to the antidiabetic drug thiazolidinediones have significantly elevated adiponectin levels despite increase fat mass (16) . An alternative explanation is that rather than displaying increased adiponectin production on HFD, the AiPKO mice may simply be resistant to the decrease in production commonly seen in wildtype mice. Therefore, circulating adiponectin may be more reliably used as a marker of insulin resistance, rather than obesity.
Selective activation of β3 adrenergic receptors with the agonist CL316,243 is known to acutely induce adipose tissue lipolysis, increase circulating free fatty acids and insulin. An increase in circulating FFAs can cause a direct activation of GPR40 on β cells, inducing granule exocytosis and increasing circulating insulin levels in the mouse (10) . We injected a low dose of the selective β3 agonist to the AiPKO mice and the controls. Although the circulating glycerol levels are significantly greater in AiPKO mice following stimulation, the NEFA levels are only mildly elevated at 5 minutes and equal at all subsequent time points. Therefore, if insulin release is triggered by NEFAs, equal amounts of insulin are expected to be released from the β cells. However, this is not the case. Despite similar levels of circulating NEFAs in AiPKOs following β3 stimulation, their insulin levels are dramatically lower than what is seen in wildtype controls. This brings to bear strong disconnect in the current model of β3 agonist-induced insulin secretion. It remains unclear at this time what the mechanism of β3 agonist-induced insulin secretion is. There are no β3 adrenergic receptors in murine β cells, so this has to be an effect mediated by receptor activation at the level of the white adipocyte (17) . Yet, the results shown here rule out a direct effect of NEFAs.
Chronic high fat diet feeding is highly associated with inflammatory adipose tissue (18) . This inflammatory response is most notably dominated by increased macrophage infiltration and concomitant increases in local TNFα and IL-6 levels (19) . Previous reports have demonstrated that systemic inhibition of this inflammatory response through genetic through genetic means can improve the metabolic homeostasis of animals (19) . The AiPKO model demonstrates that upon maintaining adipose insulin sensitivity during HFD feeding, there is a dramatic reduction of the inflammatory response commonly observed under these conditions. Upon a short term HFD challenge (6 weeks), we see a significant reduction in TNFα secretion in the adipose depot, specifically in the subcutaneous depot. Following long-term high fat diet feeding (5 months), we see a significant reduction in the maladaptive inflammatory response in the gonadal depot as indicated by decreased overall expression of the macrophage marker F4/80, decreased IL-6 production, and decreased crown-like structure staining. These observations indicate that the maladaptive inflammatory response to high fat diet feeding is dictated, directly or indirectly, by adipose tissue insulin sensitivity. The improved local insulin sensitivity is potently cytoprotective for adipocytes, leading to reduced necrotic adipocyte cell death. This in turn leads to the reduced infiltration of macrophages infiltration and the long-term improvements in insulin sensitivity. Further, decreases in adipose tissue inflammation are known to dictate inflammatory responses in other metabolically active tissues (20) . Therefore, these findings represent a potential mechanism by which maintenance of insulin signaling in adipose tissue may reduce inflammation at distant sites.
Not unexpectedly, maintaining healthy adipose tissue function in AiPKO mice leads to potent liver-protective effects during high fat diet exposure. Adiponectin with its potent hepatoprotective actions is likely to be at least partially responsible for this phenomenon (5). Following 5 months of HFD feeding, the AiPKO livers display significantly less hepatic steatosis compared to controls. Furthermore, the livers are exquisitely sensitive to insulin stimulation as judged by increased phosphoAKT staining following IP insulin injection. This model represents an additional case of adipose tissue as a primary driver of whole body insulin sensitivity and metabolism. Many examples from our own work as well as work from others have illustrated this point, such as the observations by Kahn and colleagues who knocked out the glucose transporter Glut4 specifically from adipocytes, leading to profound systemic disturbances (4, 21) .
The model presented here is also in support of the concept that expansion of adipose tissue mass (i.e. obesity) is in fact a defensive mechanism against caloric overload. We see here that protection from diabetes during caloric overload leads to expansion of the subcutaneous depot, commonly referred to as "healthy" fat expansion. As previous studies in our laboratory have shown, expansion of adipose can have potent protective effects from the metabolic derangements seen during HFD induced insulin resistance (13, 18) . Interestingly, in the AiPKO mice, already healthy insulin sensitive adipose expands greatly in the subcutaneous depot as opposed to the gonadal. This is another example of the potent antilipotoxic effects that subcutaneous depots can confer upon the system upon "healthy" expansion.
The neutralization of excess calories by effectively storing them in adipose tissue is a central aspect of the anti-lipotoxic actions of adipose tissue expansion. Maintaining a high level of insulin sensitivity in the adipocyte is a crucial ingredient in the complex set of reactions that lead to the "healthy" expansion of adipose tissue that mediates the potent insulin-sensitizing effects of the process. Keeping the insulin-sensitivity at a high level keeps adipose tissue properly vascularized, maintains an adequate number of adipocytes and keeps the level of extracellular fibrosis at bay. The selective loss of PTEN at the level of the mature adipocyte is sufficient for this process.
Materials and methods
Animals
Animal care and experimental protocols were approved by the Institutional animal care and use committee of the University of Texas Southwestern medical center. Adiponectin-RTTA mice were produced as previously described (9) . Tre-Cre (Stock Number: 006234) and PTEN floxed mice (Stock Number: 006440) were purchased from Jackson laboratories. All experiments were done using male mice with littermate controls that were adiponectinPrtTA or TRE-cre negative. Mice were fed a standard chow diet (number 5058, LabDiet), a Dox-chow diet (600 mg kg −1 Dox; Bio-Serv), a 60% HFD (D12492, Research Diets Inc.) or a Dox-HFD (600 mg kg −1 Dox; Bio-Serv). Following weaning mice were randomly placed into cages for the remainder of their life before genotyping was performed. No other randomization was used while conducting experiments. No animals were excluded from any experiments unless they displayed obvious wounds from fighting as determined by our veterinarians.
Statistical analysis
All animal studies were designed to minimize and control for confounding variables such as mouse strain, gender, age, time of day, fasted/fed state, diet and light cycle. Based on previous studies utilizing animal models for metabolic research, we can utilize as few as 6 animals per treatment group to achieve statistical power to detect significant differences when measuring RNA, protein and blood metabolites. With the use of inducible mouse models, group sizes were increased to 10 to account for any potential variation imposed by the use of ingested gene induction agents. Metabolic cage studies were performed by a technician who was blinded as to the genotype of the mice. For all other animal work, researchers were not blinded as to genotype.
UT Southwestern Medical Center has a site license for the use of GraphPad Prism software (version 6, GraphPad, Inc. San Diego CA). All data is depicted as mean plus and minus the SEM. All experiments presented have only two groups and unpaired students T-test was utilized for statistical significance. All data compares Control mice to AiPKO mice under identical conditions. For all points * represents P-value<0.05, ** represents P-value<0.01, *** represents P-value<0.001.
Metabolic testing
Oral glucose tolerance tests were performed as previously described (15) . Briefly mice were fasted for 4 hours before being a gastric gavage of glucose at 2.5g kg −1 body weight. Glucose concentrations were measured using an oxidase-peroxidase assay (Sigma). Insulin and leptin levels were measured using commercial ELISAs from Millipore. Systemic insulin sensitivity was tested by performing an insulin tolerance test. Mice were fasted for 4 hours, and then injected with 0.5IU kg −1 body weight of Humalin-R (Eli Lilly). Blood from the tail was measured for glucose content using Contour glucometer strips (Bayer) at 0, 15, 30, 60, 90 and 120 minutes. β3 adrenergic receptor tests were performed as previously described (15) . Briefly, mice were fasted for 4 hours, at which time CL316,243 was administered intraperitoneally at 0.5mg kg −1 body weight. Blood was collected at 0, 5, 15 and 30 minutes. Glycerol and NEFA measurements were determined using free glycerol reagent (Sigma) and free fatty acid quantification kits (Wako Diagnostics-NEFA-HR2) respectively.
Quantitative RT-qPCR
RNA was isolated from tissues frozen on liquid nitrogen by homogenization in Trizol Reagent (Invitrogen) and RNA extraction using a RNAeasy RNA extraction kit (Qiagen). RNA was quantified using a Nanodrop Instrument. 800ng of RNA was used to transcribe cDNA using an Iscript kit (Invitrogen). RT-qPCR primers are listed in Supplementary Table  1 . The mRNA levels were calculated using the comparative threshold cycle (Ct) method.
Western blotting
Frozen tissue was homogenized in TNET buffer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100 with phosphatase inhibitors and protease inhibitors as described in (22) (Sigma). For adipose tissue samples, tissue was homogenized first in the absence of Triton X-100, the fat layer extracted, and Triton X-100 was then added to a final concentration of 1%. Proteins were resolved on 11% Tris-Glycine gels and then transferred to nitrocellulose membranes (Bio-Rad). Adiponectin was detected with a rabbit polyclonal antiserum (23) . pAkt (Ser473, antibody #4060) and total Akt (antibody #2920) (Cell Signaling Technology) were used (1:1,000) for insulin signaling studies. Primary antibodies were detected using a secondary IgG labeled with infrared dyes emitting at 700 nm (Li-Cor Bioscience #926-32220) or 800 nm (Li-Cor Bioscience #926-32211) (both at 1:5,000 dilutions) and then visualized on a Li-Cor Odyssey infrared scanner (Li-Cor Bioscience). The scanned data were analyzed using Odyssey Version 2.1 software (Li-Cor Bioscience).
Histology and immunofluorescence
Fat pads and livers were excised and fixed overnight in 10% PBS buffered formalin and were thereafter stored in 50% ethanol. Tissues were sectioned (5um) rehydrated and stained using H+E, or with primary antibodies to PTEN (Abcam 32199; Dilution 1:25) or Mac-2 (CL8942AP; Dilution 1:200, CEDARLANE Laboratories USA Inc.). Slides were mounted using Prolong Gold Antifade reagent with DAPI (Life Technologies).
NMR and Metabolic Cages
Metabolic measurements were obtained continuously using TSE metabolic chambers (TSE Labmaster System, Germany) in an open circuit indirect calorimetry system. Data was normalized to lean body mass as determined using a Bruker MQ10 NMR analyzer.
Adipocyte isolation
Adipocytes were isolated for confirmation of gene loss and determination of cell autonomous insulin sensitivity using a collagenase digestion similar to SVF isolation procedures (24) . Briefly, freshly isolated adipose tissue was minced and subjected to 1 hour digestion at 37°C in a PBS-collagenase buffer pH 7.4 (collagenase sigma (10 mg ml −1 ). This digest was centrifuged at 600xg for 5 minutes and the floating cells removed for RNA extraction.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. A) Serum adiponectin levels of mice fed HFD doxycycline diet for 6 weeks, quantified using a Licor Western blot scanner (N=6 control and 4 AiPKO). Full blot in Supplemental  Fig 1. B) Tissue distribution determined by Bruker MQ10 NMR analyzer expressed as percent of total body weight (N=5 both groups). C) Average food intake per mouse per hour during peak light cycle (sleep cycle, 9am-3pm) in a metabolic cage analysis. (N=4 control and 6 AiPKO). D) Average total food intake per mouse over the 4 days of metabolic cage analysis. (N=4 control and 6 AiPKOs). E) Circulating leptin levels versus body weight after 6 weeks of HFD containing doxycycline (600mg kg −1 ) in the AiPKO and Control mice as measured by ELISA (Millipore EZML-82K) (N=8 for each group) F) Gene expression in brown adipose tissue following 6 weeks of doxycycline (600mg kg −1 ) containing diet (N=3 control and 2 AiPKO) G) Respiratory exchange ratios (RERs) for day and night cycles averaged per 12 hour period per mouse. (N=4 control and 6 AiPKOs). H) Average respiratory exchange ratios for each group taken every 1.5 hours over the 4 days of metabolic cage analysis (N=4 control and 6 AiPKOs). I) Volume of consumed oxygen for day and night periods, averaged per mouse, per hour, per kilogram. (N=4 control and 6 AiPKOs). J) Average total movements per mouse during metabolic cage analysis (96 
